SUBSTANTIAL INCREASE IN ALLIED HEALTH FUNDING FOR VETERANS THROUGH DVA New fee structure heralds largest increase in provider fees in over 20 years
With
Hon Matt Keogh MP
Minister for Veterans’ Affairs &
Minister for Defence Personnel
Australian Government
Scot MacDonald
General Manager, Policy and Advocacy
Exercise & Sports Science Australia (ESSA)
Katie Lyndon,
Chief Executive Officer
Exercise & Sports Science Australia (ESSA)
Dr Rik Dawson, National President
Australian Physiotherapy Association (APA)
Diana Poole, Chair
The Australian Orthotic Prosthetic Association (AOPA)
SEGMENT
Filmed in Launceston, Canberra, Melbourne & Sydney | May 2026
The Australian Federal 2026–27 Budget included several significant announcements relating to allied health services for veterans, largely tied to the Government’s response to recommendations from the Royal Commission into Defence and Veteran Suicide.
A key measure was a substantial increase in funding for allied health services delivered through the Department of Veterans’ Affairs (DVA). The Government committed $169.7 million over five years, along with ongoing funding, to increase fees paid to allied health providers treating veterans. This was described as the largest increase to veteran allied health fees in more than two decades and applies across a broad range of professions including physiotherapy, psychology, occupational therapy, exercise physiology, podiatry, speech pathology, dietetics and social work.
The Budget also announced reforms aimed at reducing administrative burden for veterans and clinicians. From July 2027, the existing 12-session treatment cycle arrangements will be removed, meaning veterans will no longer need repeated GP referrals after each block of treatment in order to continue receiving allied health support.
Another major change was the introduction of a $5,000 annual cap on allied health spending for Veteran Card holders from 1 July 2027.
The Budget measures were positioned as part of broader reforms to improve veteran wellbeing, strengthen access to healthcare services, and modernise the delivery of care through the veterans’ health system.
The announcements also included changes to fee structures and billing practices of providers delivering care to veterans through the Department of Veterans’ Affairs (DVA) system.
The most immediate impact will come from the increase in DVA reimbursement rates across a range of allied health disciplines. For many providers, the updated fee schedule is likely to narrow the gap between DVA-funded appointments and standard private consultation fees. In recent years, some clinicians and practices had reported that DVA rates were comparatively low relative to operating costs, wage growth and rising demand for services. The increased funding may therefore improve the financial sustainability of treating veteran patients and reduce the need for practices to limit DVA bookings due to lower margins.
Australian Health Journal spoke with the Minister’s office, and a number of allied health industry groups on the announcements.
Source: Written by publisher
-
Family biz succeeds in vaccine approval & distribution
It’s been 10 years since Jenny and Karl Herz started in business. Over the past 10 years they’ve launched Biointelect and Biocelect businesses to help secure approval and distribution for new medicines into Australia.
In this Australian Health Journal interview, Jenny and Karl talk about the journey the husband and wife team took to get the Novavax COVID-19 vaccine (Nuvaxovid) approved and distributed in Australia. The journey didn’t just include talented and diverse skilled staff but also their children working in both organisations.
-
Recognising service in health regulation
In April 2023, Professor John Skerritt retired from his position of Deputy Secretary Health Products Regulation Group, a role he has been in since 2012. During his time at the TGA he had line responsibility for over 1200 staff involved in the regulation of therapeutic goods, regulation of gene technology and industrial chemicals and control of drug import, export and production.
At this year’s ARCS 2023 Conference, ARCS Australia CEO Dr Shanny Dyer paid tribute to Professor Skerritt and his service to the Australian health industry. She led a tribute with fellow industry heads, Elizabeth de Somer, CEO, Medicines Australia, Anne Harris, Managing Director, Pfizer Australia & New Zealand, Deon Schoombie, CEO, Consumer Healthcare Products Australia, Ian Burgess, CEO, Medical Technology Association of Australia and Arthur Brandwood, President ARCS Australia.
-
LIVED EXPERIENCE: Spontaneous Coronary Artery Dissection (SCAD)
Jen O’Neill is a Social Work Program Manager and mother of two from the Central Coast, NSW.
At 36, she experienced her first spontaneous coronary artery dissection (SCAD) heart attack and has since survived two further SCADs before age 43.
